Vétoquinol SA reported sales results for the fourth quarter and full year of 2012. fourth quarter 2012 sales came in at EUR 77.4 million, up 1.7% compared to the same period last year. Like for like sales were down 0.9%. The lower than expected sales is primarily attributable due destocking actions by customers in Europe during the fourth quarter.

Total 2012 sales amounted to EUR 298.3 million, up 5.0% compared to 2011. Like-for-like growth came in at 1.6%, or 3.8% after adjusting for generics competing with the Marbocyl(R) range.

The company provided operating margin guidance for 2012. 2012 operating margin excluding non-recurring items will be higher than in the previous year.